home > pmps > winter 2020 > striving to ship environmentally friendly
Pharmaceutical Manufacturing and Packing Sourcer

Striving to Ship Environmentally Friendly

The challenges that we, as human beings, face today in protecting the environment are changing the way we think and act, both in private life and in business. As global warming continues at a rapid pace, researchers and scientists from a wide range of disciplines believe that adapting to climate change is the greatest challenge of the 21st century in economic, social, and environmental terms (1).

The industrial sector plays a major role in the emission of CO2. Therefore, all factors related to the product lifecycle and the transportation of goods are at the heart of a worldwide movement. Thus, it is inevitable to implement innovative strategies to reduce CO2 emissions and develop new forms of management towards more corporate social responsibility.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
About the author

Aat van der Meer was born in 1962 in Rotterdam, the Netherlands. As the son of a transport entrepreneur, he was infected with the logistics virus at a young age. After 26 years of experience in transport and logistics, Aat joined Dachser, one of the world’s leading third-party logistics providers, in 2006 and established a new Dachser branch in the Netherlands. In 2007, he became Managing Director of Dachser in the Netherlands and, two years later, also in Belgium. In 2013 and 2014, Luxembourg and the air and sea freight activities in the Benelux were added to his responsibilities.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

Industry Events

World Vaccine Congress Washington

7-9 April 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement